Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add more filters










Database
Language
Publication year range
1.
Theranostics ; 10(10): 4530-4543, 2020.
Article in English | MEDLINE | ID: mdl-32292513

ABSTRACT

Rationale: Intraoperative bleeding impairs physicians' ability to visualize the surgical field, leading to increased risk of surgical complications and reduced outcomes. Bleeding is particularly challenging during endoscopic-assisted surgical resection of hypervascular tumors in the head and neck. A tool that controls bleeding while marking tumor margins has the potential to improve gross tumor resection, reduce surgical morbidity, decrease blood loss, shorten procedure time, prevent damage to surrounding tissues, and limit postoperative pain. Herein, we develop and characterize a new system that combines pre-surgical embolization with improved visualization for endoscopic fluorescence image-guided tumor resection. Methods: Silk-elastinlike protein (SELP) polymers were employed as liquid embolic vehicles for delivery of a clinically used near-infrared dye, indocyanine green (ICG). The biophysical properties of SELP, including gelation kinetics, modulus of elasticity, and viscosity, in response to ICG incorporation using rheology, were characterized. ICG release from embolic SELP was modeled in tissue phantoms and via fluorescence imaging. The embolic capability of the SELP-ICG system was then tested in a microfluidic model of tumor vasculature. Lastly, the cytotoxicity of the SELP-ICG system in L-929 fibroblasts and human umbilical vein endothelial cells (HUVEC) was assessed. Results: ICG incorporation into SELP accelerated gelation and increased its modulus of elasticity. The SELP embolic system released 83 ± 8% of the total ICG within 24 hours, matching clinical practice for pre-surgical embolization procedures. Adding ICG to SELP did not reduce injectability, but did improve the gelation kinetics. After simulated embolization, ICG released from SELP in tissue phantoms diffused a sufficient distance to deliver dye throughout a tumor. ICG-loaded SELP was injectable through a clinical 2.3 Fr microcatheter and demonstrated deep penetration into 50-µm microfluidic-simulated blood vessels with durable occlusion. Incorporation of ICG into SELP improved biocompatibility with HUVECs, but had no effect on L-929 cell viability. Principle Conclusions: We report the development and characterization of a new, dual-functional embolization-visualization system for improving fluorescence-imaged endoscopic surgical resection of hypervascular tumors.


Subject(s)
Biopolymers/therapeutic use , Embolization, Therapeutic/methods , Fibroins/therapeutic use , Fibronectins/therapeutic use , Neoplasms/therapy , Optical Imaging , Recombinant Fusion Proteins/therapeutic use , Surgery, Computer-Assisted , Animals , Cell Line , Gels/therapeutic use , Human Umbilical Vein Endothelial Cells , Humans , Indocyanine Green/chemistry , Margins of Excision , Mice , Viscosity
2.
Biomaterials ; 217: 119293, 2019 10.
Article in English | MEDLINE | ID: mdl-31276948

ABSTRACT

Interstitial cystitis (IC), also known as painful bladder syndrome, is a debilitating chronic condition with many patients failing to respond to current treatment options. Rapid clearance, mucosal coating, and tight epithelium create strong natural barriers that reduce the effectiveness of many pharmacological interventions in the bladder. Intravesical drug delivery (IDD) is the administration of therapeutic compounds or devices to the urinary bladder via a urethral catheter. Previous work in improving IDD for IC has focused on the sustained delivery of analgesics within the bladder and other small molecule drugs which do not address underlying inflammation and bladder damage. Therapeutic glycosaminoglycans (GAG) function by restoring the mucosal barrier within the bladder, promoting healing responses, and preventing irritating solutes from reaching the bladder wall. There is an unmet medical need for a therapy that provides both acute relief of symptoms while alleviating underlying physiological sources of inflammation and promoting healing within the urothelium. Semi-synthetic glycosaminoglycan ethers (SAGE) are an emerging class of therapeutic GAG with intrinsic anti-inflammatory and analgesic properties. To reduce SAGE clearance and enhance its accumulation in the bladder, we developed a silk-elastinlike protein polymer (SELP) based system to enhance SAGE IDD. We evaluated in vitro release kinetics, rheological properties, impact on bladder function, pain response, and bladder inflammation and compared their effectiveness to other temperature-responsive polymers including Poloxamer 407 and poly(lactic-co-glycolic acid)-poly(ethylene glycol). SAGE delivered via SELP-enhanced intravesical delivery substantially improved SAGE accumulation in the urothelium, provided a sustained analgesic effect 24 h after administration, and reduced inflammation.


Subject(s)
Cystitis, Interstitial/drug therapy , Drug Delivery Systems , Elastin/chemistry , Glycosaminoglycans/administration & dosage , Glycosaminoglycans/therapeutic use , Polymers/chemistry , Silk/chemistry , Temperature , Animals , Anti-Inflammatory Agents/administration & dosage , Anti-Inflammatory Agents/therapeutic use , Antimicrobial Cationic Peptides , Behavior, Animal , Cathelicidins , Cystitis, Interstitial/pathology , Cystitis, Interstitial/physiopathology , Delayed-Action Preparations/therapeutic use , Disease Models, Animal , Drug Liberation , Female , Gels , Mice, Inbred C57BL , Urothelium/pathology
3.
Macromol Biosci ; 18(1)2018 01.
Article in English | MEDLINE | ID: mdl-28869362

ABSTRACT

Recombinant silk-elastinlike protein polymers (SELPs) combine the biocompatibility and thermoresponsiveness of human tropoelastin with the strength of silk. Direct control over structure of these monodisperse polymers allows for precise correlation of structure with function. This work describes the fabrication of the first SELP nanogels and evaluation of their physicochemical properties and thermoresponsiveness. Self-assembly of dilute concentrations of SELPs results in nanogels with enhanced stability over micelles due to physically crosslinked beta-sheet silk segments. The nanogels respond to thermal stimuli via size changes and aggregation. Modifying the ratio and sequence of silk to elastin in the polymer backbone results in alterations in critical gel formation concentration, stability, aggregation, size contraction temperature, and thermal reversibility. The nanogels sequester hydrophobic compounds and show promise in delivery of bioactive agents.


Subject(s)
Drug Delivery Systems , Elastin/chemistry , Polyethylene Glycols/chemistry , Polyethyleneimine/chemistry , Silk/chemistry , Biocompatible Materials/chemistry , Biocompatible Materials/therapeutic use , Elastin/therapeutic use , Humans , Nanogels , Nanoparticles/chemistry , Polyethylene Glycols/therapeutic use , Polyethyleneimine/therapeutic use , Polymers/chemistry , Polymers/therapeutic use , Protein Aggregates , Recombinant Proteins/chemistry , Recombinant Proteins/therapeutic use , Silk/therapeutic use , Thermosensing
SELECTION OF CITATIONS
SEARCH DETAIL
...